Evolent Health Inc (NYSE:EVH)
$ 23.28 0.39 (1.7%) Market Cap: 2.67 Bil Enterprise Value: 3.15 Bil PE Ratio: 0 PB Ratio: 2.55 GF Score: 73/100

Evolent Health Inc at RBC Capital Markets Global Healthcare Conference Transcript

May 17, 2022 / 07:35PM GMT
Release Date Price: $30.05 (+4.56%)
Sean Dodge
RBC Capital Markets - Analyst

Good afternoon. Thanks, everybody, for joining us here at RBC's Global Healthcare Conference. My name is Sean Dodge. I'm the healthcare IT analyst here at RBC, and I'm pleased to be joined by our next presenting company, which is Evolent Health. And here on behalf of the Company is their Chief Financial Officer, John Johnson, and Seth Frank who heads their IR. So special thanks to both of you for joining us.

John Johnson
Evolent Health, Inc. - CFO

Thank you for having us.

Questions & Answers

Sean Dodge
RBC Capital Markets - Analyst

So where I want to start was -- maybe let's just kind of level set. So Evolent is a bit different now -- bit different looking now than it was maybe three years ago, as a lot's happened. So just give us a little bit of an overview of what is Evolent now, and maybe what was the transformation that you went through over the last few years?

John Johnson
Evolent Health, Inc. - CFO

Yeah. So,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot